norethindrone acetate has been researched along with Rectal Diseases in 7 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
Rectal Diseases: Pathological developments in the RECTUM region of the large intestine (INTESTINE, LARGE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate patient satisfaction at 6-months dienogest (DNG) treatment in women with symptomatic rectovaginal endometriosis who had pain persistence and were unsatisfied after 6-months of norethisterone acetate (NETA) therapy." | 9.19 | Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment. ( Ferrero, S; Morotti, M; Remorgida, V; Sozzi, F; Venturini, PL, 2014) |
| "To evaluate the efficacy, safety, and tolerability of an estrogen-progestogen combination versus low-dose norethindrone acetate in the treatment of persistent pain after surgery for symptomatic rectovaginal endometriosis." | 9.11 | Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. ( Chiodini, A; Crosignani, PG; De Giorgi, O; Pasin, R; Pietropaolo, G; Vercellini, P, 2005) |
| "To study the efficacy of long-term treatment with norethindrone acetate (NETA) in patients with rectovaginal endometriosis." | 7.85 | Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis. ( Biscaldi, E; Calanni, L; Ferrero, S; Morotti, M; Racca, A; Stabilini, C; Vellone, VG; Venturini, PL, 2017) |
| "The administration of letrozole and norethisterone acetate reduces pain and gastrointestinal symptoms of women with colorectal endometriosis, particularly when patients suffer from symptoms mimicking diarrhoea-predominant irritable bowel syndrome." | 7.76 | Letrozole and norethisterone acetate in colorectal endometriosis. ( Biscaldi, E; Camerini, G; Ferrero, S; Ragni, N; Remorgida, V; Seracchioli, R; Venturini, PL, 2010) |
| "To evaluate patient satisfaction at 6-months dienogest (DNG) treatment in women with symptomatic rectovaginal endometriosis who had pain persistence and were unsatisfied after 6-months of norethisterone acetate (NETA) therapy." | 5.19 | Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment. ( Ferrero, S; Morotti, M; Remorgida, V; Sozzi, F; Venturini, PL, 2014) |
| "To evaluate the efficacy, safety, and tolerability of an estrogen-progestogen combination versus low-dose norethindrone acetate in the treatment of persistent pain after surgery for symptomatic rectovaginal endometriosis." | 5.11 | Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. ( Chiodini, A; Crosignani, PG; De Giorgi, O; Pasin, R; Pietropaolo, G; Vercellini, P, 2005) |
| "To study the efficacy of long-term treatment with norethindrone acetate (NETA) in patients with rectovaginal endometriosis." | 3.85 | Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis. ( Biscaldi, E; Calanni, L; Ferrero, S; Morotti, M; Racca, A; Stabilini, C; Vellone, VG; Venturini, PL, 2017) |
| "The administration of letrozole and norethisterone acetate reduces pain and gastrointestinal symptoms of women with colorectal endometriosis, particularly when patients suffer from symptoms mimicking diarrhoea-predominant irritable bowel syndrome." | 3.76 | Letrozole and norethisterone acetate in colorectal endometriosis. ( Biscaldi, E; Camerini, G; Ferrero, S; Ragni, N; Remorgida, V; Seracchioli, R; Venturini, PL, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morotti, M | 2 |
| Venturini, PL | 5 |
| Biscaldi, E | 3 |
| Racca, A | 1 |
| Calanni, L | 1 |
| Vellone, VG | 1 |
| Stabilini, C | 1 |
| Ferrero, S | 6 |
| Sozzi, F | 1 |
| Remorgida, V | 5 |
| Camerini, G | 2 |
| Ragni, N | 3 |
| Seracchioli, R | 1 |
| Leone Roberti Maggiore, U | 1 |
| Scala, C | 1 |
| Di Luca, M | 1 |
| Vercellini, P | 1 |
| Pietropaolo, G | 1 |
| De Giorgi, O | 1 |
| Pasin, R | 1 |
| Chiodini, A | 1 |
| Crosignani, PG | 1 |
| Abbamonte, HL | 1 |
| Fulcheri, E | 1 |
4 trials available for norethindrone acetate and Rectal Diseases
| Article | Year |
|---|---|
Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment.
Topics: Adult; Contraceptives, Oral; Endometriosis; Female; Follow-Up Studies; Humans; Nandrolone; Norethind | 2014 |
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies.
Topics: Adult; Aromatase Inhibitors; Calcium; Cholecalciferol; Contraceptives, Oral, Sequential; Contracepti | 2013 |
Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate.
Topics: Adolescent; Adult; Confidence Intervals; Drug Therapy, Combination; Endometriosis; Estrogen Replacem | 2005 |
Letrozole and norethisterone acetate in rectovaginal endometriosis.
Topics: Administration, Oral; Aromatase Inhibitors; Contraceptives, Oral, Synthetic; Drug Therapy, Combinati | 2007 |
3 other studies available for norethindrone acetate and Rectal Diseases
| Article | Year |
|---|---|
Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis.
Topics: Adult; Cohort Studies; Dyspareunia; Endometriosis; Female; Humans; Norethindrone; Norethindrone Acet | 2017 |
Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study.
Topics: Adult; Colonic Diseases; Endometriosis; Female; Humans; Norethindrone; Norethindrone Acetate; Pain; | 2010 |
Letrozole and norethisterone acetate in colorectal endometriosis.
Topics: Abdominal Pain; Aromatase Inhibitors; Colonic Diseases; Diarrhea; Drug Therapy, Combination; Dyspare | 2010 |